Brilliant Blue G
Generic Name: brilliant blue g
Brand Names:
Tissueblue
TissueBlue 0.025% - Description section TissueBlue (Brilliant Blue G Ophthalmic Solution) 0.025% is a sterile solution of BBG (a dye) for intraocular ophthalmic use. Each mL of TissueBlue 0.025% contains BBG 0.25 mg, polyethylene glycol and buffered sodium chloride solution (sodium chloride, dibasic sodium phosphate, monobasic sodium phospage, water for injection). Phosphoric acid and/or sodium hydroxide may also be used for pH adjustment.
Overview
TissueBlue 0.025% - Description section TissueBlue (Brilliant Blue G Ophthalmic Solution) 0.025% is a sterile solution of BBG (a dye) for intraocular ophthalmic use. Each mL of TissueBlue 0.025% contains BBG 0.25 mg, polyethylene glycol and buffered sodium chloride solution (sodium chloride, dibasic sodium phosphate, monobasic sodium phospage, water for injection). Phosphoric acid and/or sodium hydroxide may also be used for pH adjustment.
Uses
TissueBlue 0.025% - Indications & Usage Section TissueBlue 0.025% is indicated to selectively stain the internal limiting membrane (ILM). TissueBlue 0.025% is a disclosing agent indicated to selectively stain the internal limiting membrane (ILM).
Dosage
TissueBlue 0.025% - Dosage & Administration Section TissueBlue 0.025% is carefully injected into the Balanced Salt Solution (BSS)-filled vitreous cavity using a blunt cannula attached to the pre-filled syringe, without allowing the cannula to contact the retina or allowing TissueBlue to get under the retina. Sufficient staining is expected within a few seconds. Following staining, all excess dye should be removed from the vitreous cavity. Inject TissueBlue 0.025% directly in a Balanced Salt Solution (BSS)-filled vitreous cavity. Excess TissueBlue should be removed from the vitreous cavity.
Side Effects
TissueBlue 0.025% - Adverse Reactions section Adverse reactions that have been reported in procedures that included the use of Brilliant Blue G Ophthalmic Solution have often been associated with the surgical procedure. These complications include retinal (retinal break, tear, hemorrhage, and detachment) and cataracts. Adverse reactions that have been reported in procedures that included the use of TissueBlue 0.025% have often been associated with the surgical procedure. The complications include retinal (retinal break, tear, hemorrhage, and detachment and cataracts. To report SUSPECTED ADVERSE REACTIONS, contact Dutch Ophthalmic, USA at 1-800-75-DUTCH or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Warnings
TissueBlue 0.025% - Warnings and Precautions section Excessive Staining Excess TissueBlue 0.025% should be removed from the eye immediately after staining. Use of the Syringe Make sure the plunger moves smoothly before injecting the solution. Do not use the product if the plunger does not move smoothly to prime the cannula. Excessive staining: Excess TissueBlue 0.025% should be removed from the eye immediately after staining. Use of the syringe: Make sure the plunger moves smoothly before injecting the solution. TissueBlue 0.025% - Contraindications section None None
Pregnancy
TissueBlue 0.025% - Pregnancy section Risk Summary There are no available data on the use of TissueBlue 0.025% in pregnant women to inform a drug associated risk. Systemic absorption of TissueBlue 0.025% in humans is expected to be negligible following intravitreal injection and subsequent removal of the drug at the completion of surgical procedures. Due to the negligible systemic exposure, it is not expected that maternal use of TissueBlue 0.025% will result in fetal exposure to the drug. Adequate animal reproduction studies were not conducted with TissueBlue 0.025%.
Storage
TissueBlue 0.025% - Storage and Handling section TissueBlue 0.025% should be stored at 15°C to 25°C (59°F to 77°F). Protect from light, frost and moisture.
Frequently Asked Questions
What is Brilliant Blue G used for?▼
TissueBlue 0.025% - Indications & Usage Section TissueBlue 0.025% is indicated to selectively stain the internal limiting membrane (ILM). TissueBlue 0.025% is a disclosing agent indicated to selectively stain the internal limiting membrane (ILM).
What are the side effects of Brilliant Blue G?▼
TissueBlue 0.025% - Adverse Reactions section Adverse reactions that have been reported in procedures that included the use of Brilliant Blue G Ophthalmic Solution have often been associated with the surgical procedure. These complications include retinal (retinal break, tear, hemorrhage, and detachment) and cataracts. Adverse reactions that have been reported in procedures that included the use of TissueBlue 0.025% have often been associated with the surgical procedure. The complications include retinal (retinal break, tear, hemorrhage, and detachment and cataracts. To report SUSPECTED ADVERSE REACTIONS, contact Dutch Ophthalmic, USA at 1-800-75-DUTCH or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Can I take Brilliant Blue G during pregnancy?▼
TissueBlue 0.025% - Pregnancy section Risk Summary There are no available data on the use of TissueBlue 0.025% in pregnant women to inform a drug associated risk. Systemic absorption of TissueBlue 0.025% in humans is expected to be negligible following intravitreal injection and subsequent removal of the drug at the completion of surgical procedures. Due to the negligible systemic exposure, it is not expected that maternal use of TissueBlue 0.025% will result in fetal exposure to the drug. Adequate animal reproduction studies were not conducted with TissueBlue 0.025%.
What are the important warnings for Brilliant Blue G?▼
TissueBlue 0.025% - Warnings and Precautions section Excessive Staining Excess TissueBlue 0.025% should be removed from the eye immediately after staining. Use of the Syringe Make sure the plunger moves smoothly before injecting the solution. Do not use the product if the plunger does not move smoothly to prime the cannula. Excessive staining: Excess TissueBlue 0.025% should be removed from the eye immediately after staining. Use of the syringe: Make sure the plunger moves smoothly before injecting the solution. TissueBlue 0.025% - Contraindications section None None
Related Medications
Atropa Belladonna, Berberis Vulgaris Root Bark, Milk Thistle, Chelidonium Majus, Citrullus Colocynthis Fruit Pulp, Dioscorea Villosa Tuber, Goldenseal, Lycopodium Clavatum Spore, Sodium Sulfate, Strychnos Nux-vomica Seed, Phosphorus, Anemone Pulsatilla, Veratrum Album Root
atropa belladonna, berberis vulgaris root bark, milk thistle, chelidonium majus, citrullus colocynthis fruit pulp, dioscorea villosa tuber, goldenseal, lycopodium clavatum spore, sodium sulfate, strychnos nux-vomica seed, phosphorus, anemone pulsatilla, veratrum album root
Non-Standardized Plant Allergenic Extract [EPC]
USES: Temporarily relieves flatulence, constipation, and belching.**
Dark Temptation 48h Sweat And Odor Protection Antiperspirant
dark temptation 48h sweat and odor protection antiperspirant
Purpose antiperspirant
Allium Cepa, Antimon Tart, Arnica, Baptisia, Eupatorium Perf, Gelsemium, Kali Bic, Lachesis, Mer Iod Rub, Sticta , Sulphur Iod, Urtica Ur
allium cepa, antimon tart, arnica, baptisia, eupatorium perf, gelsemium, kali bic, lachesis, mer iod rub, sticta , sulphur iod, urtica ur
Non-Standardized Food Allergenic Extract [EPC]
PURPOSE: Temporarily relieves the common symptoms of cold and flu, including: sinus congestion achiness chills headache and fever º Natural º Gluten & Lactose free º No artificial flavors or colors º Vegetarian º No known negative side effects º No known negative drug interactions
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.